# Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage

> **NCT00841529** · PHASE2 · TERMINATED · sponsor: **Medtronic Cardiovascular** · enrollment: 40 (actual)

## Conditions studied

- Left Atrial Appendage Occlusion

## Interventions

- **DEVICE:** Medtronic LAA Occlusion Device

## Key facts

- **NCT ID:** NCT00841529
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Medtronic Business Decision
- **Last updated:** 2012-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841529, "Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00841529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*